Streetbeat News

UPH

UpHealth Inc

https://www.gigcapital2.com/

Industry

Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)

uphealth is built by forward-thinking industry experts bringing together a comprehensive platform to patients seeking medical care at any location.

Open

0.29

Mkt cap

5.3M

Volume

349K

High

0.30

P/E Ratio

-0.07

52-wk high

3.19

Low

0.25

Div yield

N/A

52-wk low

0.25

Trading of UpHealth's shares (UPH) has resumed after being temporarily halted.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:23 pm

UpHealth Inc. (UPH) shares experienced a trading halt due to a circuit breaker after a rapid increase in stock price, which surged 16.4%.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:19 pm

Shares of UpHealth (UPH) were halted on a circuit breaker due to a rapid increase in price, with the stock surging 10.2%.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 3:13 pm

UpHealth reported its Q3 adjusted EPS at $2.92, with sales reaching $32.70M, a decrease from the previous year's $38.67M.

Portfolio Pulse from Benzinga Newsdesk

November 20, 2023 | 10:42 pm

UpHealth, Inc. has entered into a definitive agreement to sell its Cloudbreak Health business to private equity firm GTCR for $180 million. The transaction is expected to provide UpHealth with significant capital to focus on its core businesses and strategic initiatives.

Portfolio Pulse from Benzinga Newsdesk

November 16, 2023 | 9:06 pm

UpHealth, Inc.'s subsidiary, Thrasys, Inc., has filed for voluntary reorganization under Chapter 11 of the U.S. Bankruptcy Code. This follows UpHealth Holdings, Inc.'s Chapter 11 filing on September 19, 2023. UpHealth, Inc. and its other subsidiaries, Cloudbreak Health, LLC and TTC Healthcare, Inc., have not filed for Chapter 11 protection and continue to operate normally. The company also announced that Behavioral Health Services, LLC, which discontinued operations earlier this year, filed for Chapter 11 protection.

Portfolio Pulse from Benzinga Newsdesk

October 20, 2023 | 2:31 pm

UpHealth, Inc. (NYSE:UPH) has announced a CEO transition with Martin Beck replacing Samuel Meckey effective October 6, 2023. Beck, who has been UpHealth's CFO since February 2020, will also join the Board of Directors. The company also announced the elimination of 20 corporate roles to mitigate the financial impact of a recent court decision in favor of Needham & Company LLC. The organizational changes do not impact the company's business units.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 12:40 pm

During Tuesday's intraday session, several healthcare stocks experienced significant movements. Gainers included Avinger, Elutia, Longeveron Inc. - Subscription Right, Applied Therapeutics, Streamline Health Solns, and PAVmed. Losers included UpHealth, Heart Test Laboratories, CareCloud, Histogen, Inhibikase Therapeutics, and MSP Recovery.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 5:31 pm

UpHealth's subsidiary, UpHealth Holdings, has filed for Chapter 11 bankruptcy, leading to a decrease in UpHealth's share prices.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 1:19 pm

During Tuesday's pre-market session, several healthcare stocks experienced significant movements. Longeveron Inc., Avinger, Navidea Biopharmaceutical, Elutia, ABVC BioPharma, and Akili saw increases in their shares, with Longeveron Inc. leading with a 172.7% increase. On the other hand, UpHealth, 60 Degrees, T2 Biosystems, SCWorx, Kinnate Biopharma, and MSP Recovery saw decreases in their shares, with UpHealth experiencing the largest decline of 50%.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 1:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.